Medicine News and Research

RSS

Research suggests possibility of using cell transplants to treat schizophrenia

Research from the School of Medicine at The University of Texas Health Science Center at San Antonio suggests the exciting possibility of using cell transplants to treat schizophrenia.

10 Sep 2013

New drug delivery system using NDs allows for direct application of chemotherapy to brain tumors

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new drug delivery system using nanodiamonds (NDs) that allows for direct application of chemotherapy to brain tumors with fewer harmful side effects and better cancer-killing efficiency than existing treatments.

10 Sep 2013

Children's National receives grant to identify early signs of prenatal brain injury caused by CHD

Children's National Medical Center has received a five-year grant from the National Institutes of Health to identify reliable early signs of prenatal brain injury caused by congenital heart disease. Catherine Limperopoulos, PhD, Director of the Advanced Pediatric Brain Imaging Research Laboratory at Children's National will lead the study.

10 Sep 2013

Scientists find link between early-onset Parkinson's and 22q11.2 deletion syndrome

Scientists at the Centre for Addiction and Mental Health (CAMH) and University Health Network (UHN) have found a new link between early-onset Parkinson's disease and a piece of DNA missing from chromosome 22. The findings help shed new light on the molecular changes that lead to Parkinson's disease.

10 Sep 2013

Ferritin protects kidneys against damage by controlling iron

A protein, ferritin, protects kidneys against a damaging after-effect of injury, heart failure or hardened arteries by controlling levels of iron, according to a study published today by researchers at the University of Alabama at Birmingham in the Journal of Clinical Investigation.

10 Sep 2013

UCSF scientists identify new way to manipulate immune system from autoimmune diseases

Scientists from UC San Francisco have identified a new way to manipulate the immune system that may keep it from attacking the body-s own molecules in autoimmune diseases such as type 1 diabetes, rheumatoid arthritis and multiple sclerosis.

10 Sep 2013

Dementia catheterization rate a ‘cause for concern’

Researchers from the UK have found that patients with dementia presenting in primary care with urinary incontinence are significantly more likely to receive pharmacologic treatment or be catheterized than other patients.

9 Sep 2013

Once-daily COPD portfolio data from Novartis presented at European Respiratory Society (ERS) Annual Congress

Novartis announced new analyses of data for once-daily Ultibro® Breezhaler® (investigational QVA149 - indacaterol 85 mcg/glycopyrronium 43 mcg delivered dose, equivalent to 110 mcg/50 mcg metered dose per capsule), which showed significant improvements in lung function, shortness of breath and health-related quality of life for chronic obstructive pulmonary disease (COPD) patients versus all comparators1,2. These data were part of 39 respiratory abstracts presented at the European Respiratory Society (ERS) Annual Congress in Barcelona, Spain.

9 Sep 2013

S&P Capital IQ commences Standard & Poor's Factual Stock Report coverage on Epigenomics AG

S&P Capital IQ announced today that it has commenced Standard & Poor's Factual Stock Report coverage on Epigenomics AG.

7 Sep 2013

Researchers investigate importance of STAT1 phosphorylation in NK cells

Since its discovery in the early 1990s, the protein STAT1 (Signal Transducer and Activator of Transcription 1) has been found to be central in passing signals across immune cells, ensuring that our bodies react quickly and appropriately to threats from viruses or other pathogens.

7 Sep 2013

Viewpoints: Administration is 'fighting back' on Obamacare; Democrats' 'nervous breakdown' about GOP inquiry on navigators

In Washington, Republican members of the House Committee on Energy and Commerce have sent intimidating letters to many of the groups hired as navigators, demanding all their paperwork and suggesting that the groups intend to exploit the work for fund-raising or political purposes.

7 Sep 2013

Amendments to oral cancer bill would increase co-pay for oral cancer treatment, says NPAF

Citing the hardships certain to be faced by a population of California cancer patients on strained incomes, the National Patient Advocate Foundation (NPAF), a national non-profit organization providing the patient voice for legislative reform at the state and federal levels, pulled its support for AB 219 following amendments passed in the California state senate yesterday that would prohibitively increase the co-pay for oral cancer treatment.

7 Sep 2013

Penn’s ITMAT symposium addresses topics of direct relevance to translational science

The Institute for Translational Medicine and Therapeutics' 7th Annual International Symposium (ITMAT) symposium, Harnessing the Paradox: Personalization and the Science of Scale, to be held in October 2013, will address topics of direct relevance to translational science.

7 Sep 2013

New book debunks popular myths on how to prevent cancer

Award-winning science journalist George Johnson debunks popular assumptions about how to prevent cancer.

7 Sep 2013

Adheris files suit against HHS for attempting to restrain speech that serves public health interest

Adheris, Inc., an inVentiv Health company, filed suit today against the U.S. Department of Health and Human Services, asking a federal court to enjoin the government from implementing a new regulation that imposes unconstitutional restrictions on the speech of a company whose business is encouraging patients to properly take their medicine.

7 Sep 2013

Enzymatics buys Boulder-based ArcherDx

Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.

7 Sep 2013

Research roundup: The financial burden of hospital acquired infections

Health care–associated infections (HAIs) account for a large proportion of the harms caused by health care and are associated with high costs. ... [Using a simulation, the researchers found that the] total annual costs for the 5 major infections were $9.8 billion (95% CI, $8.3-$11.5 billion), with surgical site infections contributing the most to overall costs (33.7% of the total), followed by ventilator-associated pneumonia (31.6%), central line–associated bloodstream infections (18.9%), C difficile infections (15.4%), and catheter-associated urinary tract infections (<1%). ... recent analyses indicate that at least 50% are preventable. ...

7 Sep 2013

D&A PHARMA to present 3 clinical studies for ALCOVER in 14th Congress of ESBRA at Warsaw

D&A PHARMA, a leading company in the Addiction therapeutic area, announces today its strong participation in the 14th Congress of European Company of Biomedical Search on the Alcoholism (ESBRA), which will be held in Warsaw from September 8th to 11th.

7 Sep 2013

FUJIFILM SonoSite gets CE mark approval for X-Porte Ultrasound Kiosk

FUJIFILM SonoSite, Inc., specialists in designing cutting-edge ultrasound tools and world-leading education for access to point-of-care visualization, today announced CE mark approval for its newest generation of point-of-care ultrasound: the X-Porte Ultrasound Kiosk.

7 Sep 2013

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.

7 Sep 2013

Medicine News and Research

Research suggests possibility of using cell transplants to treat schizophrenia

New drug delivery system using NDs allows for direct application of chemotherapy to brain tumors

Children's National receives grant to identify early signs of prenatal brain injury caused by CHD

Scientists find link between early-onset Parkinson's and 22q11.2 deletion syndrome

Ferritin protects kidneys against damage by controlling iron

UCSF scientists identify new way to manipulate immune system from autoimmune diseases

Dementia catheterization rate a ‘cause for concern’

Once-daily COPD portfolio data from Novartis presented at European Respiratory Society (ERS) Annual Congress

S&P Capital IQ commences Standard & Poor's Factual Stock Report coverage on Epigenomics AG

Researchers investigate importance of STAT1 phosphorylation in NK cells

Viewpoints: Administration is 'fighting back' on Obamacare; Democrats' 'nervous breakdown' about GOP inquiry on navigators

Amendments to oral cancer bill would increase co-pay for oral cancer treatment, says NPAF

Penn’s ITMAT symposium addresses topics of direct relevance to translational science

New book debunks popular myths on how to prevent cancer

Adheris files suit against HHS for attempting to restrain speech that serves public health interest

Enzymatics buys Boulder-based ArcherDx

Research roundup: The financial burden of hospital acquired infections

D&A PHARMA to present 3 clinical studies for ALCOVER in 14th Congress of ESBRA at Warsaw

FUJIFILM SonoSite gets CE mark approval for X-Porte Ultrasound Kiosk

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News